 |
The Department of UrologyDivision of Urologic OncologyProstate Cancer Program |
For more information, go to:
http://urology.ucla.edu |
AT UCLA, we offer the latest and most advanced care for both early and late stage prostate cancer. Our faculty are fellowship trained in urologic oncology and have been consistently ranked among the top prostate cancer practitioners in the United States. For early stage, localized prostate cancer, we offer the entire gamut of procedures, including nerve-sparing radical prostatectomy (RRP), robotically-assisted laparoscopic prostatectomy (RLRP), laparoscopic prostatectomy (LRP), brachytherapy and cryotherapy. We work closely with our radiation therapy colleagues to offer both low dose-rate and high dose-rate (HDR) brachytherapy as well as intensity modulated radiation therapy (IMRT). We monitor our results closely with databases and quality of life studies in order to improve the quality of our care and in order to better inform patients about the risk and benefits of all treatments. Our overriding philosophy is that no one treatment is appropriate for all individuals and that treatments need to be tailored to the disease and to the individual's own values and goals.
Because of the extensive basic and translational research done at UCLA in prostate cancer, we are actively studying new forms of treatment for patients with high-risk, locally advanced and metastatic prostate cancers. These include studies of molecularly targeted small molecules and antibodies, the latest in drugs that are able to target the genetic changes in an individual's tumors while sparing normal tissues. We are also on the leading edge of studies of nutrition and alternative medicines for prostate cancer.
The Prostate Cancer Program at UCLA is a nationally acknowledged center of excellence which received the National Cancer Institute designation as a Specialized Program of Research Excellence (SPORE) in 2002 - one of only 11 in the country. In 2001, the State of California acknowledged UCLA's leadership in the fight against prostate cancer by awarding the Department of Urology $50 million to administer IMPACT, a statewide prostate cancer awareness and treatment program targeting uninsured men.
| Director | Specialty |
|---|---|
| Reiter, Robert MD | Urology |
Physician |
|
| Belldegrun, Arie MD | Urology |
| Chin, Arnold MD, PhD | Urology |
| DeKernion, Jean MD | Urology |
| Leff, David MD | Urology |
| Litwin, Mark MD | Urology |
| Orecklin, James MD | Urology |
| Rajfer, Jacob MD | Urology |
| Rettig, Matthew MD | Medical Oncology |
| Smith, Robert MD | Urology |
Medical Oncology
Urology
Body System Locations
Kidneys and Urinary System
Male Reproductive System
Age/Sex Gender
Men's Health
Disorders and Conditions
Cancers
